Scinai Immunotherapeutics SCNI
NASDAQ SCNI
$2.93 -0.01 (-0.34%)
As of: Aug 21, 2026 · 12:29 PM EDT

Scinai Immunotherapeutics (SCNI) Receivables - Net (2015 - 2026)

Scinai Immunotherapeutics (SCNI) posted Receivables - Net of $150.0 million for Q1 2026, up 105.48% sequentially from $73.0 million in Q4 2025.

Scinai Immunotherapeutics (SCNI) Receivables - Net (2015 - 2026) Analysis & Trends

Scinai Immunotherapeutics has reported Receivables - Net for 12 years, with the latest figure at $150.0 million in Q1 2026.

  • Quarterly Receivables - Net changed N/A year-over-year to $150.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $150.0 million (changed N/A YoY) and the FY2025 annual result came in at $73.0 million, up 87851.81% from the prior year.
  • Receivables - Net rose to $150.0 million in Q1 2026 per SCNI's latest filing, from $73.0 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $150.0 million in Q1 2026 and troughed at $83000.0 in Q4 2024.
  • A 5-year average of $20.9 million and a median of $179000.0 in 2022 frame the typical range for Receivables - Net.
  • The sharpest annual moves came in 2022 and 2025: Receivables - Net tumbled 99.99% in 2022, then jumped 87851.81% in 2025.
  • Over 5 years, Receivables - Net stood at $202000.0 in 2022, then declined by 24.75% to $152000.0 in 2023, then sank by 45.39% to $83000.0 in 2024, then surged by 87851.81% to $73.0 million in 2025, then soared by 105.48% to $150.0 million in 2026.
  • According to Business Quant data, Receivables - Net over the past three periods registered $150.0 million, $73.0 million, and $139000.0 for Q1 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.70 Bn 131.85 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.74 Bn 78.75 Bn 3.93 Bn
3 Argenx Se 65.36 Bn 60.18 Bn 1.37 Bn
4 Moderna 59.15 Bn 54.01 Bn 52.00 Mn
5 BeOne Medicines 42.12 Bn 37.02 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.88 Bn 28.57 Bn 992.69 Mn
7 BioNTech SE 28.14 Bn 9.75 Bn 668.28 Mn
8 Insmed 27.59 Bn 26.43 Bn 358.27 Mn
9 Royalty Pharma 27.31 Bn 26.48 Bn -
10 Scinai Immunotherapeutics 11.09 Mn -3.10 Bn -1.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 150.00 Mn
Mar 31, 2026 150.00 Mn
Dec 31, 2025 73.00 Mn
Dec 31, 2025 73.00 Mn
Jun 30, 2025 139,000.00
Jun 30, 2025 139,000.00
Dec 31, 2024 83,000.00
Dec 31, 2024 83,000.00
Sep 30, 2024 120,000.00
Sep 30, 2024 120,000.00
Jun 30, 2024 119,000.00
Jun 30, 2024 119,000.00
Dec 31, 2023 152,000.00
Dec 31, 2023 152,000.00
Jun 30, 2023 5.83 Mn
Jun 30, 2023 5.83 Mn
Sep 30, 2022 202,000.00
Sep 30, 2022 202,000.00
Jun 30, 2022 179,000.00
Jun 30, 2022 179,000.00